Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer

Recruiting now · Not applicable

Conditions studied: Esophagus Cancer

In brief

The aim of this study is to compare outcomes in Chinese patients with locally advanced resectable esophageal squamous cell cancer who have received either surgery or definitive chemoradiation (CRT) by the randomized, open-label, multicenter trial.

Key facts

Study ID

NCT02972372

Run by

The First Affiliated Hospital of Henan University of Science and Technology

People needed

196

Starts

2016-11-01

Expected to finish

2027-12-01

Last updated by the study team

2025-02-10

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Chinese
• esophageal squamous cell cancer
• mid or lower esophageal cancer
• tumor is resectable disease
• clinical stage: cT1bN+Mo, or cT2-4aN0-2M0

You may not qualify if…

• who had distant metastasis to solid visceral organs or local invasion into trachea, descending aorta, or recurrent laryngeal nerve.
• who had a serious premorbid condition or a poor physical status that compromised a thoracotomy.

Where it is running

• Anyang Tumor Hospital — Anyang, Henan, China (enrolling)
• The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology — Luoyang, Henan, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.